Salbutamol Completed Phase 4 Trials for Obliterative Bronchiolitis Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT01112241Bronchodilator Responsiveness in Obliterative Bronchiolitis